Biotest Aktiengesellschaft
(OTC) BIESF
Biotest Aktiengesellschaft Financials at a Glance
Market Cap
$1.27B
Revenue (TTM)
$635.20M
Net Income (TTM)
$24.50M
EPS (TTM)
$-0.66
P/E Ratio
-48.65
Dividend
$0.05
Beta (Volatility)
-0.02 (Low)
Dividend
$0.05
Beta (Volatility)
-0.02 (Low)
Price
$31.95
Volume
93
Open
$31.95
Price
$31.95
Volume
93
Open
$31.95
Previous Close
$31.95
Daily Range
$31.95 - $31.95
52-Week Range
$31.95 - $32.00
Dividend
$0.05
Beta (Volatility)
-0.02 (Low)
Price
$31.95
Volume
93
Open
$31.95
Previous Close
$31.95
Daily Range
$31.95 - $31.95
52-Week Range
$31.95 - $32.00
BIESF News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Biotest Aktiengesellschaft
Industry
Biotechnology
Sector
Health CareEmployees
2,495
CEO
Peter Janssen, MBA
Website
www.biotest.deHeadquarters
Dreieich, 63303, DE
BIESF Financials
Key Financial Metrics (TTM)
Gross Margin
20%
Operating Margin
0%
Net Income Margin
-8%
Return on Equity
-5%
Return on Capital
0%
Return on Assets
-2%
Earnings Yield
-2.06%
Dividend Yield
0.00%
Payout Ratio
-6.43%
Stock Overview
Market Cap
$1.27B
Shares Outstanding
39.57M
Volume
93
Short Interest
0.00%
Avg. Volume
1.5
Financials (TTM)
Gross Profit
$223.80M
Operating Income
$94.50M
EBITDA
$120.40M
Operating Cash Flow
$60.90M
Capital Expenditure
$28.70M
Free Cash Flow
$32.20M
Cash & ST Invst.
$119.50M
Total Debt
$597.20M
Biotest Aktiengesellschaft Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$124.20M
-42.3%
Gross Profit
$14.10M
-84.4%
Gross Margin
11.35%
N/A
Market Cap
$1.27B
N/A
Market Cap/Employee
$507.53K
N/A
Employees
2,495
N/A
Net Income
$21.40M
-172.5%
EBITDA
$9.53M
-115.8%
Quarterly Fundamentals
Net Cash
$626.90M
-5.5%
Accounts Receivable
$195.00M
N/A
Inventory
$523.70M
+19.4%
Long Term Debt
$639.80M
+49.0%
Short Term Debt
$28.90M
-89.0%
Return on Assets
-1.76%
N/A
Return on Invested Capital
0.03%
N/A
Free Cash Flow
$58.10M
-400.9%
Operating Cash Flow
$58.10M
-400.9%